NASHVILLE, TN
September 26-27, 2017
Omni Hotel

AN ACTION-ORIENTED SUMMIT ON THE DATA AND DIGITAL INFRASTRUCTURE PRECISION MEDICINE NEEDS TO THRIVE

Precision Medicine is facing significant barriers to broad acceptance and implementation.

Solutions must carefully consider the big picture and the practical realities of a complex, multi-stakeholder environment.

Leaders in this ecosystem currently do not have a combined forum to discuss and define the formation and growth of the Genetic Health Information Network.

Precision Medicine is facing significant barriers to broad acceptance and implementation.

Solutions must carefully consider the big picture and the practical realities of a complex, multi-stakeholder environment.

Leaders in this ecosystem currently do not have a combined forum to discuss and define the formation and growth of the Genetic Health Information Network.

An intimate meeting of influential leaders from across in the Genetic Health Information Network

Representing all stakeholders in this ecosystem, including
  • Health plans
  • Clinicians
  • Hospital systems
  • Researchers
  • Policy makers
  • Patients & Advocates
  • Laboratories
  • IT Vendors
  • Pharma

Organizing Committee

(in alphabetical order)
Mara Aspinall

CEO

Health Catalysts

Michael Astion, MD, PhD

Medical Director, Department of Laboratories

Seattle Children’s Hospital

Suzanne Belinson, PhD, MPH

Executive Director

Blue Cross Blue Shield Association

Carlos Bustamante, PhD

Chair, Department of Biomedical Data Science

Stanford University

Gillian Hooker, PhD, ScM, LCGC

VP, Clinical Development

Concert Genetics

Howard Levy, MD, PhD

Associate Professor of Medicine

Johns Hopkins Medicine

Lee N. Newcomer, MD, MHA

SVP, Oncology and Genetics

UnitedHealthcare

Robert Nussbaum, MD

Chief Medical Officer

Invitae

Dee Anna Smith

CEO

Sarah Cannon and Sarah Cannon Research Institute

Benjamin Solomon, MD, FACMG

Managing Director

GeneDx

The only multi-stakeholder gathering focused on solving the data, digital infrastructure, and economic challenges facing precision medicine

Intimate, carefully curated, invitation-only gathering

Full spectrum of stakeholders

Focused on needs and solutions

Collaborative, discussion-oriented format

Chatham-house rules — non-attribution

No vendors or marketing lists

Published conference summary and recommendations

The only multi-stakeholder gathering focused on solving the data, digital infrastructure, and the economic challenges facing precision medicine

Intimate, carefully curated, invitation-only gathering

Full spectrum of stakeholders

Focused on needs and solutions

Collaborative, discussion-oriented format

Chatham-house rules — non-attribution

No vendors or marketing lists

Published conference summary and recommendations

Identify and resolve practical barriers facing precision medicine by

  • Improving the capture of clinical effectiveness and economic value data
  • Simplifying the test ordering and resulting workflow for clinicians, hospitals and labs
  • Streamlining the genetic test billing, adjudication and payment process
  • Reducing the frequency of misordered tests and surprise bills for patients
  • Empowering patients to harness the insights in their genetic makeup for greater health

Speakers & Agenda

To view the Summit agenda, click here

Lee N. Newcomer, MD

SVP, Oncology and Genetics

UnitedHealthcare

Robert C. Green, MD, MPH

Director, Genomes2People

Division of Genetics at Brigham and Women’s Hospital, the Broad Institute and Harvard Medical School

Suzanne Belinson, PhD, MPH

Executive Director

Blue Cross and Blue Shield Association

Mary E. Freivogel, MS, CGC

President

National Society of Genetic Counselors

Dan Roden, MD

Senior Vice President, Personalized Medicine

Vanderbilt University Medical Center

Nicole Boice

Founder & CEO

Global Genes

Paul W. Radensky, MD

Partner

McDermott Will & Emery

Carlos Bustamante, PhD

Chair, Department of Biomedical Data Science

Stanford University

David McCallie, MD

SVP, Medical Informatics

Cerner

Edward Abrahams, PhD

President

Personalized Medicine Coalition

Lisa Schlager

VP, Community Affairs & Public Policy

‎FORCE (Facing Our Risk of Cancer Empowered)

Taha Kass-Hout, MD

Former 1st Chief Health Informatics Officer

U.S. Food and Drug Administration (FDA)

Mara Aspinall

CEO

Health Catalysts

Robert Nussbaum, MD

Chief Medical Officer

Invitae

This event is by invitation only. If you would like to nominate somebody, including yourself, to participate in the summit, please complete the following form: